MedPath
TGA Approval

SKYRIZI risankizumab 180 mg/1.2 mL solution for injection pre-filled cartridge with on-body delivery system (427219)

427219

SKYRIZI risankizumab 180 mg/1.2 mL solution for injection pre-filled cartridge with on-body delivery system

AbbVie Pty Ltd

November 15, 2024

Medicine

Medicine

Active

Registered

Product Information

Consumer Medicine Information

https://medical-cdn.nocode.com/drug_tga/51adddacc24428a126b6c1024b93eaa8.pdf

Product Information

https://medical-cdn.nocode.com/drug_tga/251db23c825ebf280e39fb3161d6b9c4.pdf

Active Ingredients

Risankizumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SKYRIZI risankizumab 180 mg/1.2 mL solution for injection pre-filled cartridge with on-body delivery system (427219) - TGA 批准文号 | MedPath